- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Whsle Drug Dist
Snapshot for McKesson Corp (MCK)
| Open: | 115.6600 | Day's Range: | 115.4800 - 117.0000 | Volume: | 915,137 |
|---|---|---|---|---|---|
| Previous Close: | 115.4100 | 52wk Range: | 84.6540 - 117.2000 | 1-Yr Rtn: | +34.82% |
Key Statistics for MCK
| Current P/E Ratio (ttm) | 17.6305 |
|---|---|
| Estimated P/E(03/2014) | 14.5458 |
| Relative P/E vs. SPX | 1.0806 |
| Earnings Per Share (USD) (ttm) | 6.6300 |
| Est. EPS (USD) (03/2014) | 8.0360 |
| Est. PEG Ratio | 1.1189 |
| Market Cap (M USD) | 26,488.57 |
| Shares Outstanding (M) | 226.61 |
| 30 Day Average Volume | 1,173,510 |
| Price/Book (mrq) | 3.7530 |
| Price/Sale (ttm) | 0.2238 |
| Dividend Indicated Gross Yield | 0.68% |
| Cash Dividend (USD) | 0.2000 |
| Last Dividend | 02/27/2013 |
| 5 Year Dividend Growth | 27.23% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MCK
Company Profile & Key Executives for MCK
McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
| John H HammergrenChairman/President/CEO | Paul C JulianGroup President/Exec VP |
| Patrick J Blake "Pat"Group President/Exec VP | Jeffrey C CampbellExec VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MCK News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page